Patient Preferences for Recombinant Human Hyaluronidase (RHUPH20)-Facilitated Subcutaneous (SC) Infusion of Immunoglobulin G (IGHY) in Adults with Primary Immunodeficiencies (PI): Phase 3 Study Results

被引：0
|
作者：
Ito, D. [1 ]
Ye, X. [2 ]
Xiong, Y. [1 ]
Li-McLeod, J. [1 ]
Schiff, R. [1 ]
Faivre, P. [3 ]
机构：
[1] Baxter HealthCare, Med Outcomes Res & Econ, Westlake Village, CA USA
[2] Baxter HealthCare, Med Outcomes Res & Econ, Deerfield, IL USA
[3] Baxter HealthCare, Hlth Econ & Market Access, Westlake Village, Switzerland
来源：
JOURNAL OF CLINICAL IMMUNOLOGY | 2014年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
ESID-0294
引用
收藏
页码：S381 / S382
页数：2
相关论文
共 46 条
  • [21] Local Adverse Reaction Rates Decreased over Time during Treatment with Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Immunoglobulin G (IGHy) in Patients with Primary Immunodeficiency Disorders in the IGHy Phase 3 Studies
    Stein, Mark R.
    Wasserman, Richard L.
    Melamed, Isaac
    Gupta, Sudhir
    Kobrynski, Lisa J.
    Rubinstein, Arye
    Rabbat, Christopher J.
    Engl, Werner
    McCoy, Barbara
    Leibl, Heinz
    Yel, Leman
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB220 - AB220
  • [22] Tolerability and Efficacy of Facilitated-Subcutaneous Infusion of Immune Globulin (Human), 10% and Recombinant Human Hyaluronidase (Ighy) In Patients With Primary Immunodeficiency (Pi)
    Stein, Mark
    Wasserman, Richard
    Melamed, Isaac
    Rubinstein, Arye
    Engl, Werner
    Leibl, Heinz
    McCoy, Barbara
    Gelmont, David
    Schiff, Richard
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 (02) : 354 - 354
  • [23] PHARMACOKINETICS OF HUMAN IMMUNOGLOBULIN G, 10%, ADMINISTERED INTRAVENOUSLY (IGIV), SUBCUTANEOUSLY (IGSC) OR FACILITATED SUBCUTANEOUSLY WITH RECOMBINANT HUMAN HYALURONIDASE (IGHY) IN PATIENTS WITH PRIMARY IMMUNODEFICIENCIES
    Wasserman, R. L.
    Melamed, I.
    Stein, M.
    Rubinstein, A.
    Puck, J.
    Gupta, S.
    Engl, W.
    Leibl, H.
    McCoy, B.
    Gelmont, D.
    Schiff, R. I.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 : 136 - 136
  • [24] Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Immunoglobulin G (IgG) (IGHy) in Patients with Primary Immunodeficiency Disease (PIDD): Infections over Time
    Wasserman, Richard L.
    Stein, Mark R.
    Kobrynski, Lisa J.
    Gupta, Sudhir
    Grant, J. Andrew
    Rubinstein, Arye
    Rabbat, Christopher J.
    Engl, Werner
    McCoy, Barbara
    Leibl, Heinz
    Yel, Leman
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB219 - AB219
  • [25] Real-World Use of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Immunoglobulin G (IG) (IGHy) in Patients with Primary Immunodeficiency Disorders (PIDD)
    Rosenbach, Kevin P.
    Hughes, Stephanie
    Rozen, Leon
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB220 - AB220
  • [26] Modeled Economic Impact of Facilitated-Subcutaneous Infusion of Immune Globulin (Human), 10% with Recombinant Human Hyaluronidase (IGHy) or Intravenous Immunoglobulin (IGIV) in Primary Immunodeficiency (PI) Patients
    Iyer, Ravi
    Luo, Michelle
    Li-McLeod, Josephine
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 (02) : 397 - 397
  • [27] LOCAL ADVERSE REACTION RATES DECREASED OVER TIME DURING RECOMBINANT HUMAN HYALURONIDASE-FACILITATED SUBCUTANEOUS INFUSION OF IMMUNOGLOBULIN G (IgG) (IGHy) TREATMENT IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISORDERS (PIDD) IN THE IGHy PHASE 3 STUDIES
    Stein, Mark
    Wasserman, Richard L.
    Melamed, Isaac
    Gupta, Sudhir
    Kobrynski, Lisa
    Rubenstein, Arye
    Rabbat, Christopher
    Engl, Werner
    McCoy, Barbara
    Leibl, Heinz
    Yel, Leman
    JOURNAL OF CLINICAL IMMUNOLOGY, 2016, 36 (03) : 269 - 270
  • [28] Long-Term Safety and Pharmacokinetics of Facilitated Subcutaneous Infusion of Immune Globulin (Human) 10% and Recombinant Human Hyaluronidase (IGHy) in a Phase III Extension Study in Patients with Primary Immunodeficiency (PI)
    Melamed, Isaac
    Wasserman, Richard
    Stein, Mark
    Rubenstein, Arye
    Puck, Jennifer
    Gupta, Sudhir
    Engl, Werner
    Leibl, Heinz
    Gelmont, David
    Schiff, Richard
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 (02) : 363 - 363
  • [29] LONG-TERM SAFETY AND PHARMACOKINETICS OF FACILITATED-SUBCUTANEOUS INFUSION OF HUMAN IMMUNE GLOBULIN G, 10%, AND RECOMBINANT HUMAN HYALURONIDASE: PHASE 3 EXTENSION STUDY IN PATIENTS WITH PRIMARY IMMUNODEFICIENCIES
    Melamed, I.
    Wasserman, R.
    Stein, M. R.
    Rubinstein, A.
    Puck, J.
    Gupta, S.
    Engl, W.
    Leibl, H.
    Gelmont, D. M.
    Schiff, R. I.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 109 (05) : A98 - A99
  • [30] TOLERABILITY AND SAFETY OF RECOMBINANT HUMAN HYALURONIDASE-FACILITATED SUBCUTANEOUS INFUSION OF HUMAN IMMUNE GLOBULIN G, 10%, IN PATIENTS WITH PRIMARY IMMUNODEFICIENCIES: A STUDY FROM NORTH AMERICA
    Kobayashi, R.
    Stein, M. R.
    Darter, A.
    Paris, K.
    Gupta, S.
    Testori, A.
    Engl, W.
    Leibl, H.
    Filhauer, K.
    Schiff, R. I.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 109 (05) : A98 - A98
12345